Amedeo Smart

Free Medical Literature Service



Gastric Cancer

  Free Subscription

Articles published in
Int J Cancer
    November 2022
  1. YANG H, Wang XK, Wang JB, Zhao FH, et al
    Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population.
    Int J Cancer. 2022;151:1462-1473.
    >> Share

    August 2022
  2. LEE SH, Lee Y, Jang HJ
    Deep learning captures selective features for discrimination of microsatellite instability from pathologic tissue slides of gastric cancer.
    Int J Cancer. 2022 Aug 19. doi: 10.1002/ijc.34251.
    >> Share

    June 2022
  3. QIAN Y, Zhai E, Chen S, Liu Y, et al
    Single-cell RNA-seq dissecting heterogeneity of tumor cells and comprehensive dynamics in tumor microenvironment during lymph nodes metastasis in gastric cancer.
    Int J Cancer. 2022 Jun 18. doi: 10.1002/ijc.34172.
    >> Share

  4. WANG S, Zheng R, Arnold M, Abnet C, et al
    Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34158.
    >> Share

    April 2022
  5. COLLATUZZO G, Etemadi A, Sotoudeh M, Nikmanesh A, et al
    Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran.
    Int J Cancer. 2022 Apr 30. doi: 10.1002/ijc.34056.
    >> Share

    March 2022
  6. WU F, Yang L, Hao Y, Zhou B, et al
    Oral and gastric microbiome in relation to gastric intestinal metaplasia.
    Int J Cancer. 2022;150:928-940.
    >> Share

    November 2021
  7. QU Y, Wang X, Bai S, Niu L, et al
    The effects of TNF-alpha/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.
    Int J Cancer. 2021 Nov 11. doi: 10.1002/ijc.33873.
    >> Share

  8. PEREIRA C, Park JH, Campelos S, Gullo I, et al
    Comparison of East-Asia and West-Europe cohorts explains disparities in survival outcomes and highlights predictive biomarkers of early gastric cancer aggressiveness.
    Int J Cancer. 2021 Nov 9. doi: 10.1002/ijc.33872.
    >> Share

  9. HOGNER A, Al-Batran SE, Siveke JT, Lorenz M, et al
    Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: a randomized phase-II study - the PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510.
    Int J Cancer. 2021 Nov 6. doi: 10.1002/ijc.33864.
    >> Share

  10. GU J, Xie S, Wang S, Xue L, et al
    Surveillance of premalignant gastric cardia lesions: A population-based prospective cohort study in China.
    Int J Cancer. 2021;149:1639-1648.
    >> Share

    October 2021
  11. YANG Y, Long J, Wang C, Blot WJ, et al
    Prospective Study of Oral Microbiome and Gastric Cancer Risk Among Asian, African American and European American Populations.
    Int J Cancer. 2021 Oct 18. doi: 10.1002/ijc.33847.
    >> Share

    September 2021
  12. CABASAG CJ, Arnold M, Pineros M, Morgan E, et al
    Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
    Int J Cancer. 2021;149:1239-1246.
    >> Share

    August 2021
  13. KAWAI S, Wang C, Lin Y, Sasakabe T, et al
    Lifetime incidence risk for gastric cancer in the Helicobacter pylori-infected and uninfected population in Japan: A Monte Carlo simulation study.
    Int J Cancer. 2021 Aug 27. doi: 10.1002/ijc.33773.
    >> Share

    June 2021
  14. JAYASEKARA H, MacInnis RJ, Lujan-Barroso L, Mayen-Chacon AL, et al
    Lifetime alcohol intake, drinking patterns over time and risk of stomach cancer: A pooled analysis of data from two prospective cohort studies.
    Int J Cancer. 2021;148:2759-2773.
    >> Share

    May 2021
  15. HOFHEINZ RD, Hegewisch-Becker S, Kunzmann V, Thuss-Patience P, et al
    Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study G
    Int J Cancer. 2021 May 21. doi: 10.1002/ijc.33696.
    >> Share

  16. COLLATUZZO G, Pelucchi C, Negri E, Lopez-Carrillo L, et al
    Exploring the interactions between Hp infection and other risk factors of gastric cancer: a pooled analysis in the Stomach cancer Pooling (StoP) Project.
    Int J Cancer. 2021 May 14. doi: 10.1002/ijc.33678.
    >> Share

    April 2021
  17. NESS-JENSEN E, Bringeland EA, Mattsson F, Mjones P, et al
    Hypergastrinemia is associated with an increased risk of gastric adenocarcinoma with proximal location: A prospective population-based nested case-control study.
    Int J Cancer. 2021;148:1879-1886.
    >> Share

  18. LIU C, Song K, Hu Q, Hu C, et al
    Having gastroesophageal cancer is associated with increased risk of severe COVID-19-related events in patients with digestive tract cancer: A multicenter, retrospective, cohort study.
    Int J Cancer. 2021;148:1789-1793.
    >> Share

    January 2021
  19. WATANABE Y, Oikawa R, Kodaka Y, Sato Y, et al
    Cancer-related genetic variants of Helicobacter pylori strains determined using gastric wash-based whole-genome analysis with single-molecule real-time technology.
    Int J Cancer. 2021;148:178-192.
    >> Share

    December 2020
  20. KATAGIRI R, Goto A, Shimazu T, Yamaji T, et al
    Dietary fiber intake and risk of gastric cancer: the Japan Public Health Center-based prospective study.
    Int J Cancer. 2020 Dec 21. doi: 10.1002/ijc.33450.
    >> Share

  21. CHOI J, Jia G, Wen W, Long J, et al
    Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
    Int J Cancer. 2020;147:3416-3423.
    >> Share

  22. EL KHADIR M, Boukhris Alaoui S, Benajah DA, Ibrahimi SA, et al
    VacA genotypes and cagA-EPIYA-C motifs of Helicobacter pylori and gastric histopathological lesions.
    Int J Cancer. 2020;147:3206-3214.
    >> Share

    November 2020
  23. LI B, Cheung KS, Wong IY, Leung WK, et al
    Calcium channel blockers are associated with lower gastric cancer risk: a territory-wide study with propensity score analysis.
    Int J Cancer. 2020 Nov 5. doi: 10.1002/ijc.33379.
    >> Share

  24. CANZIAN F, Rizzato C, Obazee O, Stein A, et al
    Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions.
    Int J Cancer. 2020;147:2437-2445.
    >> Share

  25. LORENZEN S, Knorrenschild JR, Pauligk C, Hegewisch-Becker S, et al
    Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC).
    Int J Cancer. 2020;147:2493-2502.
    >> Share

  26. GARCIA RODRIGUEZ LA, Soriano-Gabarro M, Vora P, Cea Soriano L, et al
    Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
    Int J Cancer. 2020;147:2394-2404.
    >> Share

    October 2020
  27. LV K, Li R, Cao Y, Gu Y, et al
    LAG-3 expression associates with poor prognosis and immunoevasive contexture in EBV-positive and MLH1-defective gastric cancer patients.
    Int J Cancer. 2020 Oct 26. doi: 10.1002/ijc.33358.
    >> Share

    September 2020
  28. LADIGAN-BADURA S, Vangala DB, Engel C, Bucksch K, et al
    Value of upper GI endoscopy for gastric cancer surveillance in patients with Lynch syndrome.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33294.
    >> Share

    August 2020
  29. CARIOLI G, Bertuccio P, Malvezzi M, Rodriguez T, et al
    Cancer mortality predictions for 2019 in Latin America.
    Int J Cancer. 2020;147:619-632.
    >> Share

    June 2020
  30. FERRO A, Costa AR, Morais S, Bertuccio P, et al
    Fruits and vegetables intake and gastric cancer risk: a pooled analysis within the Stomach cancer Pooling (StoP) Project.
    Int J Cancer. 2020 Jun 11. doi: 10.1002/ijc.33134.
    >> Share

    May 2020
  31. HOLLECZEK B, Schottker B, Brenner H
    Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population-based ESTHER cohort study.
    Int J Cancer. 2020;146:2773-2783.
    >> Share

    March 2020
  32. SEO EH, Kim HJ, Kim JH, Lim B, et al
    ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
    Int J Cancer. 2020 Mar 4. doi: 10.1002/ijc.32946.
    >> Share

    December 2019
  33. BORNSCHEIN J, Wernisch L, Secrier M, Miremadi A, et al
    Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
    Int J Cancer. 2019;145:3389-3401.
    >> Share

  34. HUANG SC, Ng KF, Yeh TS, Cheng CT, et al
    Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
    Int J Cancer. 2019;145:3218-3230.
    >> Share

    November 2019
  35. JANG J, Wang T, Cai H, Ye F, et al
    The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: a nested case-control study from eight East Asian cohort studies.
    Int J Cancer. 2019 Nov 19. doi: 10.1002/ijc.32790.
    >> Share

    October 2019
  36. UMEDA S, Kanda M, Miwa T, Tanaka H, et al
    Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer.
    Int J Cancer. 2019 Oct 9. doi: 10.1002/ijc.32705.
    >> Share

  37. FERRO A, Rosato V, Rota M, Costa AR, et al
    Meat intake and risk of gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Int J Cancer. 2019 Oct 4. doi: 10.1002/ijc.32707.
    >> Share

    August 2019
  38. PIZZI MP, Bartelli TF, Pelosof AG, Freitas HC, et al
    Identification of DNA mutations in gastric washes from gastric adenocarcinoma patients: Possible implications for liquid biopsies and patient follow-up.
    Int J Cancer. 2019;145:1090-1098.
    >> Share

    July 2019
  39. DIJKSTERHUIS WPM, Verhoeven RHA, Slingerland M, Haj Mohammad N, et al
    Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: a real-world evidence study.
    Int J Cancer. 2019 Jul 24. doi: 10.1002/ijc.32580.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016